ReviewFuture oncology (London, England)2025

Combination niraparib and abiraterone for HRR-altered metastatic castration-resistant prostate cancer.

Hayley Nicole Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.